Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset October 22, 2024
Exclusive: FOCAC promotes solidarity of Global South, boost modernization: South Africa FM October 15, 2024